Jun 22, 2026 09:05AM
Jun 22, 2026 08:30AM
Jun 4, 2026 07:30AM
Jun 4, 2026 07:30AM
May 28, 2026 04:01PM
May 21, 2026 06:00PM
May 21, 2026 06:00PM Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 14, 2026 07:16AM
May 14, 2026 06:59AM
May 14, 2026 06:59AM
May 8, 2026 02:30AM
May 8, 2026 02:30AM
May 7, 2026 04:01PM
Apr 30, 2026 04:01PM Stoke Therapeutics to Host Webcast and Conference Call to Discuss First Quarter 2026 Business and Financial Updates
Apr 8, 2026 04:01PM
Apr 7, 2026 04:01PM
Apr 7, 2026 04:01PM
Mar 31, 2026 06:59AM
Mar 31, 2026 06:59AM
Mar 30, 2026 09:24AM
Mar 30, 2026 07:30AM FDA approves high dose SPINRAZA for spinal muscular atrophy
Mar 30, 2026 07:30AM
Mar 28, 2026 03:00PM
Mar 28, 2026 03:00PM
Mar 20, 2026 12:13PM
Mar 20, 2026 12:05PM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting
Mar 5, 2026 07:30AM
Mar 4, 2026 05:05PM
Feb 24, 2026 04:01PM
Feb 11, 2026 05:00PM
Feb 11, 2026 05:00PM
Feb 9, 2026 06:37AM
Feb 6, 2026 02:00AM Biogen earnings preview Q4: set for weaker print, Leqembi outlook in focus
Feb 4, 2026 04:01PM
Feb 4, 2026 07:30AM
Feb 4, 2026 07:30AM
Jan 28, 2026 07:30AM
Jan 28, 2026 07:30AM
Jan 25, 2026 11:52PM
Jan 25, 2026 06:30PM FDA accepts LEQEMBI IQLIK application for weekly Alzheimer's treatment
Jan 25, 2026 06:30PM
Jan 12, 2026 11:06AM
Jan 12, 2026 11:05AM
Jan 11, 2026 02:00PM
Jan 11, 2026 02:00PM
Dec 5, 2025 09:01AM
Dec 5, 2025 09:00AM Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 America
Dec 5, 2025 09:00AM

323,884 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All